Synchron: Funding, Investors & Team (Aug 2026)
Synchron is a leading implantable brain computer interface company. The stentrode is the first commercial implantable brain computer interface to receive an FDA IDE for in human clinical trials.
Synchron has raised $275M across 3 funding rounds on record, the most recent a Series D of $200M announced in Nov 2025.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Synchron Company Profile and Key Stats
Latest funding round on record: Nov 2025.
Synchron Funding Rounds
Synchron raised $100k in an Undisclosed announced in Feb 2022.
10 months later, a Series C of $75.0M was announced in Dec 2022.
2.9 years later, a Series D of $200M was announced in Nov 2025.
Synchron Founders and Leadership Team
Contact details for the Synchron team: 2 of 2 have an email address on file.
Start 14-day free trial →Synchron Funding Compared to Other Health Care Startups
Synchron's latest round of $200M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Synchron in Health Care and New York
Companies Similar to Synchron
https://metriport.com
There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…
Serif Health provides healthcare price intelligence and contract management solution.
Switchboard Health provides virtual care solutions to payers, health systems, employers, and at-risk…
Astek Diagnostics has designed a system that helps doctors choose the right antibiotics for patients…
TECLens is developing a crosslinking technology that can effectively address vision problems in both healthy…
Healthcare Shares operates as a crowdfunding portal for the transformative medical innovations of the future.
Gradient Health collaborates with medical data providers worldwide to assemble diseases and conditions for AI…
Kalivir designs safe and potent oncolytic product candidates across multiple tumor types. Kalivir’s…
Happy Health is a mission-driven technology company committed to transforming mental health awareness through…
Leal Therapeutics creates new treatments for patients.
Teal Health is on a mission to empower women when it comes to their health – starting with at-home cervical…
Synchron Funding FAQs
What does Synchron do?
Synchron is a leading implantable brain computer interface company. The stentrode is the first commercial implantable brain computer interface to receive an FDA IDE for in human clinical trials.
How much funding has Synchron raised?
Synchron has raised $275M across 3 rounds on record. The most recent is a Series D of $200M announced in Nov 2025.
When did Synchron last raise funding?
Synchron's most recent funding round on record is a Series D of $200M, announced in Nov 2025.
Who founded Synchron?
FundedIQ lists Nicholas Opie (Founder) at Synchron.
Who is the CEO of Synchron?
Thomas Oxley is listed as CEO at Synchron.
Where is Synchron headquartered?
Synchron is based in New York, United States.
How many employees does Synchron have?
Synchron is in the 101-250 employee band.
How does Synchron's funding compare to other Health Care startups?
Synchron's latest round of $200M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Synchron Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Synchron is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.